Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study

BACKGROUND: Immune thrombocytopenia (ITP) is characterized by primarily autoantibody-mediated platelet destruction and impaired platelet production resulting in thrombocytopenia and an increased risk of bleeding. Other manifestations include increased risk of thrombosis and diminished quality of lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuter, David J., Bussel, James B., Ghanima, Waleed, Cooper, Nichola, Gernsheimer, Terry, Lambert, Michele P., Liebman, Howard A., Tarantino, Michael D., Lee, Michelle, Guo, Hailing, Daak, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585997/
https://www.ncbi.nlm.nih.gov/pubmed/37869360
http://dx.doi.org/10.1177/20406207231205431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585997/
https://www.ncbi.nlm.nih.gov/pubmed/37869360
http://dx.doi.org/10.1177/20406207231205431

Ejemplares similares